Teams working on communications and policy were cut from the agency on Tuesday, according to multiple FDA workers interviewed by MedTech Dive.
‘Just goodbyes and crying’: CDRH hit in HHS mass layoffs Read More »
After some high-profile crashes, the one-time biotech darling is inching toward success with its Hunter syndrome treatment, which today began a rolling BLA for accelerated approval.
Denali Goes All In on Neuroscience’s Thorniest Hurdle: Crossing the Blood-Brain Barrier Read More »
Elegir cómo presentar tu trabajo final de máster no es una decisión menor. Muchos estudiantes, ante la presión del tiempo o la dificultad del tema, optan por explorar opciones externas. Una de las más populares es acudir a plataformas como Trabajos Acad&e …
¿Es buena idea comprar TFM? Una guía para tomar una decisión informada Read More »
The sweeping workforce reduction that began Tuesday was made worse by mistakes and poor communication, including directions for some CMS employees to contact a director who died last year.
‘A cruel April Fool’s joke’: HHS layoffs characterized by confusion, errors Read More »
The Food and Drug Administration, which oversees medical devices, has 3,500 jobs on the chopping block — which could hinder cybersecurity oversight, Democrats said during a House subcommittee hearing.
HHS layoffs could imperil medical device cybersecurity, Democrats say Read More »
With the recently announced layoffs of 3,500 FDA staffers and exits of branch directors Patrizia Cavazzoni and Peter Marks, there could be a wealth of talent available to biopharma companies. Does this pose an ethical quandary? It depends on who you ask.
FDA Job Cuts, Key Departures Bring ‘Revolving Door’ Debate Front and Center Read More »
The Food and Drug Administration has 3,500 jobs on the chopping block, which could hinder cybersecurity oversight, Democrats said during a House subcommittee hearing.
HHS layoffs could imperil medical device cybersecurity, Democrats say Read More »
23 states on Tuesday sued the Department of Health and Human Services over a planned $11 billion funding cut for public health projects.
Democrats Push Back on Trump Health Cuts With Lawsuits and Longest Ever Senate Speech Read More »
Trump has repeatedly called April 2 “Liberation Day,” alluding to a more sweeping and aggressive set of tariffs. Leerink Partners analysts said that the risks from Trump’s tariffs on the biopharma industry are “underappreciated.”
Drugmakers Ask Trump for Staggered Tariffs as ‘Liberation Day’ Arrives Read More »
Johnson & Johnson will not appeal the dismissal of its bankruptcy proposal.
J&J Pulls $7B Commitment as Court Swats Final Talc Settlement Plan Read More »
